Future research that standardizes these key factors or explores their combination with other means (such as erythropoietin [EPO] and other pro-cellular factors [399]) may provide new research directions for improving ventricular remodeling post-MI and lead to more desirable therapeutic outcomes. Here, EPO is linked to myocardial infarction.